Tecfidera multiple sclerosis drug

Tecfidera multiple sclerosis drug

C029/2153 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 65.6MB

Downloadable file size: 11.7MB

Price image Pricing

Please login to use the price calculator


Credit: DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Restrictions: Editorial use only

Caption: Tecfidera multiple sclerosis drug. Blisterpack for a week's worth of capsules of the drug Tecfidera (dimethyl fumarate), taken twice daily in the treatment of relapsing remitting multiple sclerosis. Tecfidera was approved for use in the USA in 2013, and in Europe in 2014. Multiple sclerosis is a progressive disorder in which the body's immune system attacks the myelin sheaths that cover nerve fibres. It can cause tingling, speech disorders, lack of coordination, paralysis and death.

Release details: Model release not required. Property release not required.

Keywords: 2016, 21st century, biogen idec, blisterpack, british, capsule, capsules, daily, day, dimethyl fumarate, drug, english, european, evening, friday, gastro-resistant hard capsules, healthcare, label, labels, medical, medicine, monday, morning, multiple sclerosis, night, no-one, nobody, packaging, packet, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pill pills, relapsing remitting multiple sclerosis, saturday, studio shot, sunday, tecfidera, thursday, treatment, tuesday, united kingdom, wednesday, week, week's worth, weekly amount, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.